Oklo Price Targets Cut to $86 and $91 as Licensing Delays Persist
Barclays cut Oklo’s price target to $86 from $146 while maintaining an Overweight rating, and Goldman Sachs trimmed its target to $91 from $106 with a Neutral stance. The firm faces licensing delays before its next NRC update even as demand for AI-driven power ramps up.
1. Price Target Reductions
Analysts at Barclays lowered Oklo’s price target from $146 to $86 while retaining an Overweight rating. Goldman Sachs followed suit, cutting its target to $91 from $106 but maintaining a Neutral stance. These revisions reflect updated assumptions on uranium market dynamics and capital requirements.
2. Licensing and Regulatory Outlook
Oklo awaits its next Nuclear Regulatory Commission update, with licensing timelines stretching longer than initially projected. The firm’s push to meet safety and regulatory milestones is crucial for advancing its Aurora Powerhouse deployment and securing commercial partnerships.
3. Reactor Development Progress
The company is progressing on its small modular fission reactors under the Aurora Powerhouse program and developing nuclear fuel recycling technologies. Demonstration of operational efficiency and cost controls will be pivotal in validating the reactors’ economic case.
4. Funding and Cost Visibility
Management emphasized the need for additional funding to support construction and R&D, underscoring clear visibility into capital costs. Analysts noted that securing project financing and clarifying regulatory cost assumptions will be key to sustaining Oklo’s development roadmap.